Skip to main content
. Author manuscript; available in PMC: 2023 May 30.
Published in final edited form as: Crit Rev Oncog. 2022;27(2):73–84. doi: 10.1615/CritRevOncog.2022044635

TABLE 1:

Classes and examples of radiosensitizers

Platinum-based compounds
Cisplatin2426 Interstrand and intrastrand crosslinking of DNA, cell cycle arrest, inhibition of DNA damage repair, inhibition of angiogenesis, generation of oxidative stress
Carboplatin24,25
Taxanes
Docetaxel27 Antimicrotubular agents, cell cycle arrest
Paclitaxel28,29
Anti-metabolites
5-FU30,32 Pyrimidine analog, inhibits DNA replication and synthesis, cell cycle arrest
Gemcitabine30,33
Methotrexate30 Folic acid analog, inhibits de novo purine and thymidine synthesis, inhibition of DNA replication
EGFR inhibitors
Cetuximab37,38 EGFR inhibition
Afatinib37
Erlotinib41
Immunotherapy
Pembrolizumab74 PD-1 inhibition
Nivolumab74
Cemiplimab49
Enzyme inhibitors
Olaparib56,59 PARP inhibitor, inhibition of DNA damage repair, hypoxia sensitizer
Valproic Acid60,63 HDAC inhibitor
CUDC-10161,62 Inhibitor of EGFR, HER and HDAC
CB-83964 Glutaminase inhibitor
Hypoxia sensitizers
Nimorazole69,70 Oxygen mimetic, increases oxidative stress
Olaparib56,59 PARP inhibitor, inhibition of DNA damage repair, hypoxia sensitizer